Franklin, MA, United States of America

Dan Deaver

This inventor holds 1 USPTO granted patent. Top assignee: Alkermes Pharma Ireland Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan Deaver. Retrieved from https://idiyas.com/inventor/dan-deaver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dan Deaver: Innovator in Pharmaceutical Chemistry

Introduction

Dan Deaver is a notable inventor based in Franklin, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on morphinan analogues.

Latest Patents

Dan Deaver holds 1 patent for his invention titled "Morphan and morphinan analogues, and methods of use." This patent relates to analogs of morphan and morphinan, compositions thereof, and methods for treating diseases or conditions by administering effective amounts of the compounds or compositions to subjects in need.

Career Highlights

Dan is currently employed at Alkermes Pharma Ireland Limited, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective treatments that can significantly improve patient outcomes.

Collaborations

Throughout his career, Dan has collaborated with esteemed colleagues, including Laura Cook Blumberg and David J Eyerman. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Dan Deaver's contributions to pharmaceutical chemistry through his patent on morphinan analogues exemplify his commitment to advancing medical science. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…